Research & Development
Zambon receives European Commission approval for Hopledo in Parkinson's disease
28 August 2026 - Italian pharmaceutical company Zambon announced on Friday that the European Commission has granted marketing authorisation for Hopledo, a first-in-class oral, modified-release formula...
Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine
28 August 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) and German biotechnology company BioNTech SE (NASDAQ:BNTX) announced on Thursday that the US Food and Drug Administration (FDA) has ...
ReviR Therapeutics' RTX-117 receives FDA Rare Pediatric Disease Designation for Charcot-Marie-Tooth disease
27 August 2026 - Clinical-stage biotechnology company ReviR Therapeutics announced on Wednesday that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to ...
Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic GEA eligible for ZIIHERA
27 August 2026 - Swiss healthcare company Roche (SIX: RO, ROG; OTCQX: RHHBY) announced on Wednesday that it has received FDA approval for expanded use of its PATHWAY HER2 (4B5) and VENTANA HER2 Dual I...
Annovis Bio schedules corporate update webinar for next week
26 August 2026 - Annovis Bio Inc (NYSE:ANVS), a Phase 3 clinical-stage biotechnology company developing an investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer�...
Cellenkos' CK0803 granted US FDA Fast Track designation for ALS
26 August 2026 - Cellenkos Inc, a clinical-stage biotechnology company developing tissue-directed, cord blood-derived T-regulatory (Treg) cell therapies, announced on Tuesday that the US Food and Drug...